Skip to main content
. 2016 Jun 30;7(49):80363–80372. doi: 10.18632/oncotarget.10345

Figure 4. SMARCA is a miR-151 target.

Figure 4

A. HEK293 cells were co-transfected with reporter constructs carrying the encoding sequence of SMARCA containing wild type or mutated miR-151 complementary site and a synthetic mimic of miR-151 or miR-control (miR-CNT). Luciferase activities were analyzed at 48 h post transfection and normalized to the level of the control Renilla luciferase. B. Detection of SMARCA endogenous expression by qPCR in MCF-7 cell lines transfected with miR-151 mimic or miR-control or with miR-151 inhibitor or miR-control inhibitor. *p < 0.005.